{
  "main_header": {
    "sid": 1003693,
    "name": "Dipna Pharmachem",
    "stock_name": "Dipna Pharmachem",
    "full_name": "Dipna Pharmachem Ltd",
    "name_url": "stocks-analysis/dipna-pharmachem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "5.00",
    "mcapval": "13.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543594,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0MC401013",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": 18000,
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/dipna-pharmachem-1003693-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "1003693",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/dipna-pharmachem-1003693"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "15-Jul-2026",
      "details": "Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended on 30th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Jul-2026",
      "details": "Announcement under Regulation 30 (LODR) - Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 2Nd July 2026",
      "datetime": "02-Jul-2026",
      "details": "Outcome of Board Meeting held today i.e. 2nd July 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Dipna Pharmachem Ltd has announced <strong>13:12</strong> rights issue, ex-date: 12 Feb 24",
          "dt": "2024-02-12",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News